Clinical Trial Update: A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

View source ↗

Summary

This clinical trial update describes a prospective registry to assess the effectiveness and local tolerability of intravesical valrubicin in non-muscle-invasive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Bladder Carcinoma in Situ

Drugs mentioned

• VALSTAR (valrubicin)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Bladder Cancer, CIS | Status: TERMINATED